Please login to the form below
Genzyme
This page shows the latest Genzyme news and features for those working in and with pharma, biotech and healthcare.
European Commission approves potential new treatment for Pompe disease
The European Commission (EC) has issued a marketing authorisation for Sanofi Genzyme’s therapy Nexviadyme (avalglucosidase alfa) for the long-term treatment of both late-onset and infantile-onset Pompe disease.
Latest news
-
2022 PM Society Awards
Other client Gold winners were Allergan Aesthetics, an AbbVie Company, Campaign Against Living Miserably (CALM), Fresenius Kabi, Greenwich BioSciences, Mölnlycke, Novo Nordisk, Roche/Chugai, Sanofi Genzyme and ViiV Healthcare.
-
FDA accepts Priority Review for Dupixent in children with moderate-to-severe atopic dermatitis
If approved, Dupixent – developed by Regeneron Pharmaceuticals and Sanofi Genzyme – would be used as a supplementary treatment for managing moderate-to-severe atopic dermatitis and is aimed at children whose condition
-
Sanofi unveils new corporate brand and logo
Sanofi Pasteur and Sanofi Genzyme will unite under the new brand image. ... Sanofi Pasteur and Sanofi Genzyme are focused on providing specialised care and vaccine research, respectively and will come together following the new branding as one united
-
Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
The latest news from Sanofi Genzyme and Regeneron Pharmaceuticals shared positive results from the second phase 3 for Dupixent (dupilumab), a medicine the companies developed to target chronic inflammatory skin diseases.
-
Results for the inaugural QiC Dermatology Awards 2021 in association with Dermatology in practice announced!
The awards took place at the Reading office of the QiC Dermatology Awards sponsor, Sanofi Genzyme. ... The awards took place at the Reading office of the QiC Dermatology Awards sponsor, Sanofi Genzyme, and were presented by Dr Hilary Jones.
More from news
Approximately 30 fully matching, plus 170 partially matching documents found.
Latest Intelligence
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
One example is Genzyme (now Sanofi Genzyme), a pioneer in the rare disease space with a focus on R&D efforts targeting enzyme replacement therapies for lysosomal storage disorders and leading ... including Shire/Takeda, Actelion/J&J, Sanofi Genzyme,
-
Case study: OptiMiSe for MS nurses
Client:Sanofi Genzyme. Agency:Vivid – A Lucid Group Company. Campaign:OptiMiSe for MS nurses: a tailored, added-value support service for clinical behaviour change towards optimised services. ... It has also resulted in Sanofi Genzyme SOM-led support
-
Case study: See Below
Client:Sanofi Genzyme and Regeneron. Agency:Havas Lynx Group. Campaign:See Below. Timescale:N/A. Atopic dermatitis affects approximately 1-3% of adults worldwide. ... Topical corticosteroids are commonly used to treat atopic dermatitis. Sanofi Genzyme
-
Innovation and digital health comms recognised at Communiqué Awards
Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.
-
Case study: The World vs MS
Client:Sanofi Genzyme. Agency:H4B Manchester. Campaign:The World vs MS. Timescale:Ongoing. The World vs MS is an ongoing, ambitious social movement that has united the world in the fight ... As the world’s first pharma-sponsored emoji, it reinforces
More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest appointments
-
Azafaros expands executive team with three senior hires
Rounding out the new hires is Louise Kooij, who joins as head of finance and operations from Sanofi-Genzyme. ... Before this, she held the position of head of business operations Europe at Sanofi-Genzyme Europe, after working as vice president, business
-
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
She has worked with global brands including Sanofi Genzyme and Novartis.
-
Lucid Group announces new hires at its creative and digital agency Bluedog
Lucid Group had a successful run at the Comm uniqué awards this year, bringing home the Excellence in Professional Education Programmes award for its company Vivid’s work for Sanofi
-
Industry appointments
Vivaldi has more than 25 years’ experience and joins the biotech with clinical and business experience, and has held leadership roles at Spark Therapeutics and Genzyme.
-
Mereo BioPharma appoints head of patient access and commercial planning
Prior to this, she served as vice president of health and market access policy at Genzyme Corporation – now part of Sanofi.
More from appointments
Approximately 4 fully matching, plus 38 partially matching documents found.
Latest from PMHub
-
Havas Lynx Group
AbbVie. ALK. Astellas. AstraZeneca. Bayer. Boehringer Ingelheim. BI. BMS. Celgene. Sanofi Genzyme.
-
Lucid Group are shortlisted in three categories for Communiqué 2020
for Sanofi Genzyme. Category: The Real Science Award for Medical Affairs Agency of the Year.
-
Lucid Group make the cut at the PMEAs 2017
OptiMiSe: a Multichannel Learning Platform for Clinical Behaviour Change Among Multiple Sclerosis Specialist Nurses, by Sanofi Genzyme, with support from Lucid Group.
-
Frontera Group
Eusa Pharma. Fresenius Kabi. Galderma . Gedeon Richter. Genzyme. Grunenthal . Leukaemia UK. ... Could mHealth save healthcare? The rare disease project has really transformed the Sanofi Genzyme rare disease franchise.
-
Lucid celebrate big wins at PMEA 2015
Success for Lucid at PMEA 2015. Lucid group successfully supported AbbVie and Genzyme to win two awards at last night’s ceremony in London. ... And they celebrated with Genzyme after supporting them to win the award for launch excellence.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Janssen announces positive results supporting Rybrevant and lazertinib combination treatment for NSCLC
- Medscape Education Receives Joint Accreditation with Commendation to Deliver Continuing Education for Healthcare Providers
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
- NHS England to roll out continuous glucose monitors to all those with type 1 diabetes
- Sanofi and Innovent Biologics to develop oncology drugs for patients in China
- WHO launches funding appeal for greater Horn of Africa prompted by food crisis
PMHub
Thrive Agency
We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...
Latest intelligence
- Animation: Living With
- The journey from the patient's perspective...
- Achieving communication excellence by targeting the right channel at the right time
- By Danny Buckland...
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
